In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sobital Drug Master File in Korea (Sobital KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sobital. The MFDS reviews the Sobital KDMF as part of the drug registration process and uses the information provided in the Sobital KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sobital KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sobital API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sobital suppliers with KDMF on PharmaCompass.